Karin Ekström Smedby

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Karin Ekström Smedby är professor i hematologi-onkologi med inriktning mot klinisk epidemiologi.

Professor in Hematology/Oncology with a focus on Clinical Epidemiology, 2021, KI
Assistent professor, 2010, KI
PhD 2005, KI
Medical Doctor, 1995, Uppsala University

Utvalda publikationer

Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(31):3463-3472

Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study

Ovlisen AK; Jakobsen LH; Eloranta S; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Dahl-Sorensen RB; Stoltenberg D; Weibull CE; Entrop JP; Glimelius I; Smedby KE; Torp-Pedersen C; Severinsen MT; El-Galaly TC
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060

Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study

Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Letter: BLOOD CANCER JOURNAL. 2021;11(5):100

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study

Wasterlid T; Hasselblom S; Joelsson J; Weibull CE; Rassidakis G; Sander B; Smedby KE
Editorial comment: LANCET HAEMATOLOGY. 2021;8(4):e242-e243

Late toxicities in non-Hodgkin lymphoma: extended follow-up matters.

Thanarajasingam G; Smedby KE; LaCasce A
Article: BLOOD ADVANCES. 2021;5(6):1638-1647

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Glimelius I; Smedby KE; Albertsson-Lindblad A; Crowther MJ; Eloranta S; Jerkeman M; Weibull CE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study

Wasterlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
Article: BLOOD CANCER JOURNAL. 2021;11(1):9

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28

Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis

Eloranta S; Smedby KE; Dickman PW; Andersson TM
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661

Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients

Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte H; Bogsted M; El-Galaly TC; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(33):JCO1800262-3323

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up

Lockmer S; Ostenstad B; Hagberg H; Holte H; Johansson A-S; Wahlin BE; Wader KF; Steen CB; Meyer P; Maisenholder M; Smedby KE; Brown P; Kimby E

Artiklar

Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2024;46:100785

Stable use of radiotherapy in lymphoma patients over time - A comprehensive national overview of radiotherapy use in Sweden with focus on older patients

Glimelius I; Ekberg S; Smedby KE; Wasterlid T
Article: ACTA ONCOLOGICA. 2024;63:164-168

Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study

Ekberg S; Molin D; Pahnke S; Bergstroem F; Branvall E; Smedby KE; Waesterlid T
Article: LEUKEMIA & LYMPHOMA. 2024;65(4):534-537

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: LEUKEMIA. 2024;38(2):610-620

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

Ren W; Wan H; Abd Own S; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini R-M; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarstrom Q
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2024;33(2):206-214

Potential for Cure by Stage across the Cancer Spectrum in the United States

Hubbell E; Clarke CA; Smedby KE; Adami H-O; Chang ET
Article: JOURNAL OF CANCER SURVIVORSHIP. 2024;:1-11

Long-term prescribed drug use in stage I-III rectal cancer patients in Sweden, with a focus on bowel-regulating drugs after surgical and oncological treatment

Boman SE; Fuentes S; Nordenvall C; Martling A; Chen L; Glimelius I; Neovius M; Smedby KE; Eloranta S
Article: FRONTIERS IN ENDOCRINOLOGY. 2024;15:1360139

Long-term risk of neoplastic events after childhood growth hormone treatment: a population-based cohort study in Sweden

Tidblad A; Bottai M; Smedby KE; Albertsson-Wikland K; Saevendahl L
Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(35):5376-5387

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY
Article: ACTA ONCOLOGICA. 2023;62(12):1599-1606

Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study

Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Stahl O; Wettergren L; Lampic C
Article: EUROPEAN JOURNAL OF CANCER. 2023;195:113403

Secondary malignancies among mantle cell lymphoma patients

Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(12):3132-3142

Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study

Olen O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov A; Askling J; Ekbom A; Sachs MC; Sorensen HT; Ludvigsson JF
Article: LANCET HAEMATOLOGY. 2023;10(10):e838-e848

Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population- based, retrospective cohort study

Trab T; Baech J; Jakobsen LH; Husby S; Severinsen MT; Eloranta S; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Larsen TS; Brown P; Gronbaek K; Smedby KE; El-Galaly TC
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;153(4):723-731

Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study

Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;202(4):785-795

Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study

Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Article: HEMASPHERE. 2023;7(8):e928

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project

Jerkeman M; Ekberg S; Glimelius I; Albertsson-Lindblad A; Entrop JP; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269

Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders

Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KEE; Pettersson A; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:474-475

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.

Visco C; Malinverni C; Florea E; Glimelius I; Mirandola M; Ekström-Smedby K; Tisi MC; Giné E; Albertsson-Lindblad A; Niebla AM; Di Rocco A; Moita F; Sciarra R; Bašić-Kinda S; Hess G; Ohler A; Eskelund C; Re A; Ferrarini I; Kolstad A; Räty R; Quaglia FM; Bernardelli A; Eyre TA; Scapinello G; Stefani PM; Morello L; Nassi L; Hohaus S; Ragaini S; Zilioli VR; Bruna R; Cocito F; Arcari A; Jerkeman M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(5):687-696

Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Argirion I; Pfeiffer RM; Proietti C; Coghill AE; Yu KJ; Middeldorp JM; Sarathkumara YD; Hsu W-L; Chien Y-C; Lou P-J; Wang C-P; Rothman N; Lan Q; Chen C-J; Mbulaiteye SM; Jarrett RF; Glimelius I; Smedby KE; Hjalgrim H; Hildesheim A; Doolan DL; Liu Z
Article: ACTA ONCOLOGICA. 2023;62(4):342-349

CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research

Weibull CEE; Boman SE; Glimelius B; Syk I; Matthiessen P; Smedby KEE; Nordenvall C; Martling A
Article: CANCER MEDICINE. 2023;12(8):9893-9901

Do young adults with cancer receive information about treatment- related impact on sex life? Results from a population-based study

Bergstrom C; Lampic C; Roy R; Hedman C; Ahlgren J; Stahl O; Smedby KE; Hellman K; Henriksson R; Eriksson LE; Wettergren L
Article: BLOOD ADVANCES. 2023;7(5):866-874

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

Ekberg S; Smedby KE; Albertsson-Lindblad A; Jerkeman M; Weibull CE; Glimelius I
Article: HEMASPHERE. 2023;7(3):e838

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Weibull CE; Wasterlid T; Wahlin BE; Andersson P-O; Ekberg S; Lockmer S; Enblad G; Crowther MJ; Kimby E; Smedby KE
Article: LEUKEMIA. 2023;37(2):339-347

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Mansouri L; Thorvaldsdottir B; Sutton L-A; Karakatsoulis G; Meggendorfer M; Parker H; Nadeu F; Brieghel C; Laidou S; Moia R; Rossi D; Catherwood M; Kotaskova J; Delgado J; Rodriguez-Vicente AE; Benito R; Rigolin GM; Bonfiglio S; Scarfo L; Mattsson M; Davis Z; Gogia A; Rani L; Baliakas P; Foroughi-Asl H; Jylha C; Skaftason A; Rapado I; Miras F; Martinez-Lopez J; de la Serna J; Rivas JMH; Thornton P; Larrayoz MJ; Calasanz MJ; Fesus V; Matrai Z; Bodor C; Smedby KE; Espinet B; Puiggros A; Gupta R; Bullinger L; Bosch F; Tazon-Vega B; Baran-Marszak F; Oscier D; N'Guyen-Khac F; Zenz T; Terol MJ; Cuneo A; Hernandez-Sanchez M; Pospisilova S; Mills K; Gaidano G; Niemann CU; Campo E; Strefford JC; Ghia P; Stamatopoulos K; Rosenquist R
Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40

Association of metformin use and survival in patients with cutaneous melanoma and diabetes

Krakowski I; Habel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98(1):23-30

Sex differences in lymphoma incidence and mortality by subtype: A population-based study

Radkiewicz C; Bruchfeld JB; Weibull CE; Jeppesen ML; Frederiksen H; Lambe M; Jakobsen L; El-Galaly TC; Smedby KE; Wasterlid T
Article: CANCER MEDICINE. 2023;12(1):315-324

Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study

Shahrivar M; Weibull CE; Ekstrom Smedby K; Glimelius B; Syk I; Matthiessen P; Nordenvall C; Martling A
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study

Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: LEUKEMIA. 2022;36(12):2835-2844

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami H-O; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JFJ; Gabbas A; Ghesquieres H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van den Berg A; Van den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
Article: RMD OPEN. 2022;8(2):e002776

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649

Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission

Ekberg S; Crowther M; Harrysson S; Jerkeman M; Smedby KE; Eloranta S
Article: ACTA ONCOLOGICA. 2022;61(10):1165-1172

Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis - a population-based study

Wettergren L; Eriksson LE; Bergstrom C; Hedman C; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Lampic C
Article: BLOOD ADVANCES. 2022;6(15):4427-4435

Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

Baech J; Severinsen MT; Ovlisen AK; Frederiksen H; Vestergaard P; Torp-Pedersen C; Jorgensen J; Clausen MR; Poulsen CB; Brown P; Gang AO; Pedersen RS; Smedby KE; Eloranta S; Jakobsen LH; El-Galaly TC
Article: ACTA ONCOLOGICA. 2022;61(8):922-930

Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study

Udumyan R; Botteri E; Jerlstrom T; Montgomery S; Smedby KE; Fall K
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients

Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;197(5):580-589

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha AR; Hollander P; Lof L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(5):1103-1110

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.

Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(5):369-378

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

Brieghel C; Galle V; Agius R; Da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
Article: BLOOD ADVANCES. 2022;6(8):2657-2666

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

Joelsson J; Wasterlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
Article: JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 2022;20(6):683-689.e2

Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer

Zeng E; He W; Smedby KE; Czene K
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(3):528-535

Use of Antibiotics and Risk of Psychiatric Disorders in Newly Diagnosed Cancer Patients: A Population-Based Cohort Study in Sweden

Hu K; Smedby KE; Sjolander A; Montgomery S; Valdimarsdottir U; Engstrand L; Fang F; Fall K
Article: BMC CANCER. 2022;22(1):75

NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden

Shen Q; Sjolander A; Sloan EK; Walker AK; Fall K; Valdimarsdottir U; Sparen P; Smedby KE; Fang F
Article: FRONTIERS IN ONCOLOGY. 2022;12:984021

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach

Ruiz NR; Abd Own S; Smedby KE; Eloranta S; Koch S; Wasterlid T; Krstic A; Boman M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560

Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2021;50(4):1325-1334

Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer.

Besson C; Moore A; Wu W; Vajdic CM; de Sanjose S; Camp NJ; Smedby KE; Shanafelt TD; Morton LM; Brewer JD; Zablotska L; Engels EA; Cerhan JR; Slager SL; Han J; Berndt SI; InterLymph Consortium. Full authors list is given
Article: ACTA ONCOLOGICA. 2021;60(8):976-983

Fertility-related information received by young women and men with cancer - a population-based survey

Wide A; Wettergren L; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Rodriguez-Wallberg K; Stahl O; Lampic C
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(3):568-579

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini R-M
Article: BLOOD ADVANCES. 2021;5(6):1671-1681

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha AR; Hollander P; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: CELLS. 2021;10(2):394

Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study.

Seyed Khoei N; Carreras-Torres R; Murphy N; Gunter MJ; Brennan P; Smith-Byrne K; Mariosa D; Mckay J; O'Mara TA; Jarrett R; Hjalgrim H; Smedby KE; Cozen W; Onel K; Diepstra A; Wagner K-H; Freisling H
Article: LEUKEMIA. 2021;35(2):476-484

Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients

Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: RHEUMATOLOGY. 2021;60(2):809-819

Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype

Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
Article: JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS. 2021;5:200-217

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.

Moore A; Machiela MJ; Machado M; Wang SS; Kane E; Slager SL; Zhou W; Carrington M; Lan Q; Milne RL; Birmann BM; Adami H-O; Albanes D; Arslan AA; Becker N; Benavente Y; Bisanzi S; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Canzian F; Caporaso N; Clavel J; Cocco P; Conde L; Cox DG; Cozen W; Curtin K; De Vivo I; de Sanjose S; Foretova L; Gapstur SM; Ghesquières H; Giles GG; Glenn M; Glimelius B; Gao C; Habermann TM; Hjalgrim H; Jackson RD; Liebow M; Link BK; Maynadie M; McKay J; Melbye M; Miligi L; Molina TJ; Monnereau A; Nieters A; North KE; Offit K; Patel AV; Piro S; Ravichandran V; Riboli E; Salles G; Severson RK; Skibola CF; Smedby KE; Southey MC; Spinelli JJ; Staines A; Stewart C; Teras LR; Tinker LF; Travis RC; Vajdic CM; Vermeulen RCH; Vijai J; Weiderpass E; Weinstein S; Doo NW; Zhang Y; Zheng T; Chanock SJ; Rothman N; Cerhan JR; Dean M; Camp NJ; Yeager M; Berndt SI
Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekstrom AM; Ekstrom M; Smedby KE; Hagstrom H; James S; Jarvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundstrom J
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(1):105-115

Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting

Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81

Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study

Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: TRANSPLANT INTERNATIONAL. 2020;33(12):1700-1710

Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study

Benoni H; Eloranta S; Dahle DO; Svensson MHS; Nordin A; Carstens J; Mjoen G; Helantera I; Hellstrom V; Enblad G; Pukkala E; Sorensen SS; Lempinen M; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785

Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia

Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;183(3):669-675

Sarcoma of the breast: breast cancer history as etiologic and prognostic factor-A population-based case-control study

Karlsson F; Granath F; Smedby KE; Zedenius J; Branstrom R; Nilsson I-L
Article: BMC MEDICINE. 2020;18(1):238

Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study

Hu K; Sjolander A; Lu D; Walker AK; Sloan EK; Fall K; Valdimarsdottir U; Hall P; Smedby KE; Fang F
Article: CANCER RESEARCH. 2020;80(16):3436-3442

Psychiatric Disorders Are Associated with Increased Risk of Sepsis Following a Cancer Diagnosis

Liu Q; Song H; Andersson TM-L; Magnusson PKE; Zhu J; Smedby KE; Fang F
Article: BJS OPEN. 2020;4(4):645-658

Increasing incidence of colorectal cancer among the younger population in Sweden

Petersson J; Bock D; Martling A; Smedby KE; Angenete E; Saraste D
Article: ACTA ONCOLOGICA. 2020;59(8):949-958

Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State

Ording AG; Christensen LB; Bjorge T; Doody DR; Ekbom A; Glimelius I; Grotmol T; Larfors G; Mueller BA; Smedby KE; Tretli S; Troisi R; Sorensen HT
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(3):608-618

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

Liu Z; Jarrett RF; Hjalgrim H; Proietti C; Chang ET; Smedby KE; Yu KJ; Lake A; Troy S; McAulay KA; Pfeiffer RM; Adami H-O; Glimelius B; Melbye M; Hildesheim A; Doolan DL; Coghill AE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BIOMEDICINES. 2020;8(6):E170-170

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

Ghaderi A; Daneshmanesh AH; Moshfegh A; Kokhaei P; Vagberg J; Schultz J; Olin T; Harrysson S; Smedby KE; Drakos E; Rassidakis GZ; Osterborg A; Mellstedt H; Hojjat-Farsangi M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092

Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study

Ekberg S; Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(6):723-733

Family history of colorectal cancer and survival: a Swedish population-based study

Pesola F; Eloranta S; Martling A; Saraste D; Smedby KE
Article: BLOOD. 2020;135(21):1859-1869

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Condoluci A; di Bergamo LT; Langerbeins P; Hoechstetter MA; Herling CD; De Paoli L; Delgado J; Rabe KG; Gentile M; Doubek M; Mauro FR; Chiodin G; Mattsson M; Bahlo J; Cutrona G; Kotaskova J; Deambrogi C; Smedby KE; Spina V; Bruscaggin A; Wu W; Moia R; Bianchi E; Gerber B; Zucca E; Gillessen S; Ghielmini M; Cavalli F; Stussi G; Hess MA; Baumann TS; Neri A; Ferrarini M; Rosenquist R; Forconi F; Foa R; Pospisilova S; Morabito F; Stilgenbauer S; Doehner H; Parikh SA; Wierda WG; Montserrat E; Gaidano G; Hallek M; Rossi D
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(5):597-605

Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients

Udumyan R; Montgomery S; Duberg A-S; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(3):225-232

Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(5):1074-1078

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.

Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):661-671

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen JM; Josefsson PL; Ovlisen AK; Holte H; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586

Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors

Wadstrom H; Pettersson A; Smedby KE; Askling J
Article: CANCER CAUSES & CONTROL. 2020;31(5):451-462

Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study

Wade NB; Chang CM; Conti D; Millstein J; Skibola C; Nieters A; Wang SS; De Sanjose S; Kane E; Spinelli JJ; Bracci P; Zhang Y; Slager S; Wang J; Hjalgrim H; Smedby KE; Brown EE; Jarrett RF; Cozen W
Article: BRITISH JOURNAL OF CANCER. 2020;122(8):1242-1249

Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study

Hesla AC; Discacciati A; Tsagkozis P; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(1):106-116

Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study

Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;51(8):789-800

Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study

Mouratidou N; Malmborg P; Sachs MC; Askling J; Ekbom A; Neovius M; Smedby KE; Savendahl L; Ludvigsson JF; Olen O
Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2020;29(3):104560

Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer

Aspberg S; Yu L; Gigante B; Smedby KE; Singer DE
Article: GUT. 2020;69(3):453-461

Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014

Olen O; Askling J; Sachs MC; Neovius M; Smedby KE; Ekbom A; Ludvigsson JF
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(3):682-691

Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients-A nationwide study

Benoni H; Eloranta S; Ekbom A; Wilczek H; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2020;29(1):70-79

Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.

Kleinstern G; Yan H; Hildebrandt MAT; Vijai J; Berndt SI; Ghesquières H; McKay J; Wang SS; Nieters A; Ye Y; Monnereau A; Brooks-Wilson AR; Lan Q; Melbye M; Jackson RD; Teras LR; Purdue MP; Vajdic CM; Vermeulen RCH; Giles GG; Cocco PL; Birmann BM; Kraft P; Albanes D; Zeleniuch-Jacquotte A; Crouch S; Zhang Y; Sarangi V; Asmann Y; Offit K; Salles G; Wu X; Smedby KE; Skibola CF; Slager SL; Rothman N; Chanock SJ; Cerhan JR
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(1):119-126

Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer

Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
Article: GENETIC EPIDEMIOLOGY. 2019;43(7):844-863

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadie M; Foretova L; Staines A; Mack TM; de Sanjose S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami H-O; Ghesquieres H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Doo NW; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud P-A; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Article: INFLAMMATORY BOWEL DISEASES. 2019;25(10):1663-1673

Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers

Malmborg P; Mouratidou N; Sachs MC; Hammar U; Khalili H; Neovius M; Hjern A; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Olen O
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208

Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients

Weibull CE; Bjorkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: CANCER MEDICINE. 2019;8(10):4918-4927

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark

Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; Brown PDN; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
Article: BMC MEDICAL GENETICS. 2019;20(1):128

A multivariable approach for risk markers from pooled molecular data with only partial overlap

Stelzer A-S; Maccioni L; Gerhold-Ay A; Smedby KE; Schumacher M; Nieters A; Binder H
Article: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(497):eaav5599

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma

Jain N; Hartert K; Tadros S; Fiskus W; Havranek O; Ma MCJ; Bouska A; Heavican T; Kumar D; Deng Q; Moore D; Pak C; Liu CL; Gentles AJ; Hartmann E; Kridel R; Smedby KE; Juliusson G; Rosenquist R; Gascoyne RD; Rosenwald A; Giancotti F; Neelapu SS; Westin J; Vose JM; Lunning MA; Greiner T; Rodig S; Iqbal J; Alizadeh AA; Davis RE; Bhalla K; Green MR
Journal article: HEMASPHERE. 2019;3(S1):106-107

PF308 PROGNOSTIC FACTORS AND IMMUNOHISTOCHEMICAL PROFILE IN PRIMARY REFRACTORY AND RECURRENT DIFFUSE LARGE B‐CELL LYMPHOMAS

Lampikoski H; Drakos E; Nummisalo E; Tzoras E; Kokaraki G; Harrysson S; Smedby KE; Rassidakis G
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):207-212

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjogren's syndrome

Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468

Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study

Wasterlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
Article: HAEMATOLOGICA. 2019;104(2):360-369

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Baliakas P; Moysiadis T; Hadzidimitriou A; Xochelli A; Jeromin S; Agathangelidis A; Mattsson M; Sutton L-A; Minga E; Scarfo L; Rossi D; Davis Z; Villamor N; Parker H; Kotaskova J; Stalika E; Plevova K; Mansouri L; Cortese D; Navarro A; Delgado J; Larrayoz M; Young E; Anagnostopoulos A; Smedby KE; Juliusson G; Sheehy O; Catherwood M; Strefford JC; Stavroyianni N; Belessi C; Pospisilova S; Oscier D; Gaidano G; Campo E; Haferlach C; Ghia P; Rosenquist R; Stamatopoulos K
Article: GASTROENTEROLOGY. 2019;156(3):614-622

Increased Mortality of Patients With Childhood- Onset Inflammatory Bowel Diseases, Compared With the General Population

Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: CLINICAL EPIDEMIOLOGY. 2019;11:1025-1034

Cardiovascular Diseases And Psychiatric Disorders During The Diagnostic Workup Of Suspected Hematological Malignancy

Liu Q; Andersson TM; Joud A; Shen Q; Schelin MEC; Magnusson PKE; Smedby KE; Fang F
Article: FRONTIERS IN ONCOLOGY. 2019;9:1539

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

Moore A; Kane E; Wang Z; Panagiotou OA; Teras LR; Monnereau A; Wong Doo N; Machiela MJ; Skibola CF; Slager SL; Salles G; Camp NJ; Bracci PM; Nieters A; Vermeulen RCH; Vijai J; Smedby KE; Zhang Y; Vajdic CM; Cozen W; Spinelli JJ; Hjalgrim H; Giles GG; Link BK; Clavel J; Arslan AA; Purdue MP; Tinker LF; Albanes D; Ferri GM; Habermann TM; Adami H-O; Becker N; Benavente Y; Bisanzi S; Boffetta P; Brennan P; Brooks-Wilson AR; Canzian F; Conde L; Cox DG; Curtin K; Foretova L; Gapstur SM; Ghesquieres H; Glenn M; Glimelius B; Jackson RD; Lan Q; Liebow M; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Morton LM; North KE; Offit K; Padoan M; Patel AV; Piro S; Ravichandran V; Riboli E; de Sanjose S; Severson RK; Southey MC; Staines A; Stewart C; Travis RC; Weiderpass E; Weinstein S; Zheng T; Chanock SJ; Chatterjee N; Rothman N; Birmann BM; Cerhan JR; Berndt SI
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(2):192-201

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha AR; Hollander P; Hedstrom G; Sundstrom C; Molin D; Smedby KE; Hjalgrim H; Glimelius I; Amini R-M; Enblad G
Article: BLOOD CANCER JOURNAL. 2018;9(1):1

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

Went M; Sud A; Speedy H; Sunter NJ; Foersti A; Law PJ; Johnson DC; Mirabella F; Holroyd A; Li N; Orlando G; Weinhold N; van Duin M; Chen B; Mitchell JS; Mansouri L; Juliusson G; Smedby KE; Jayne S; Majid A; Dearden C; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Kuiper R; Stephens OW; Bertsch U; Broderick P; Einsele H; Gregory WM; Hillengass J; Hoffmann P; Jackson GH; Joeckel K-H; Nickel J; Noethen MM; da Silva Filho MI; Thomsen H; Walker BA; Broyl A; Davies FE; Hansson M; Goldschmidt H; Dyer MJS; Kaiser M; Sonneveld P; Morgan GJ; Hemminki K; Nilsson B; Catovsky D; Allan JM; Houlston RS
Article: JCO CLINICAL CANCER INFORMATICS. 2018;2:1-13

Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study

Biccler JL; Eloranta S; Brown PDN; Frederikseri H; Jerkeman M; Jorgensen J; Jakobsen LH; Smedby KE; Bogsted M; El-Galaly TC
Article: BREAST CANCER RESEARCH. 2018;20(1):142

No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study

Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Article: NATURE COMMUNICATIONS. 2018;9(1):4182

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia

McMaster ML; Berndt SI; Zhang J; Slager SL; Li SA; Vajdic CM; Smedby KE; Yan H; Birmann BM; Brown EE; Smith A; Kleinstern G; Fansler MM; Mayr C; Zhu B; Chung CC; Park J-H; Burdette L; Hicks BD; Hutchinson A; Teras LR; Adami H-O; Bracci PM; McKay J; Monnereau A; Link BK; Vermeulen RCH; Ansell SM; Maria A; Diver WR; Melbye M; Ojesina AI; Kraft P; Boffetta P; Clavel J; Giovannucci E; Besson CM; Canzia F; Travis RC; Vineis P; Weiderpass E; Montalvan R; Wang Z; Yeager M; Becker N; Benavente Y; Brennan P; Foretova L; Maynadie M; Nieters A; de Sanjose S; Staines A; Conde L; Riby J; Glimelius B; Hjalgrim H; Pradhan N; Feldman AL; Novak AJ; Lawrence C; Bassig BA; Lan Q; Zheng T; North KE; Tinker LF; Cozen W; Severson RK; Hofmann JN; Zhang Y; Jackson RD; Morton LM; Purdue MP; Chatterjee N; Offit K; Cerhan JR; Chanock SJ; Rothman N; Vijai J; Goldin LR; Skibola CF; Caporaso NE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725

Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators

Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Bjorkholm M; Lambert PC; Dickman PW; Glimelius I
Article: CANCER RESEARCH. 2018;78(14):4086-4096

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue M-H; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami H-O; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquieres H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(4):270-275

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis

Baecklund E; Backlin C; Ronnelid J; Toes R; Huizinga TWJ; Ahlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114

Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphomaA population-based study from Sweden

Bjorkholm M; Weibull CE; Eloranta S; Smedby KE; Glimelius I; Dickman PW
Article: BLOOD. 2018;131(23):2541-2551

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Kleinstern G; Camp NJ; Goldin LR; Vachon CM; Vajdic CM; de Sanjose S; Weinberg JB; Benavente Y; Casabonne D; Liebow M; Nieters A; Hjalgrim H; Melbye M; Glimelius B; Adami H-O; Boffetta P; Brennan P; Maynadie M; McKay J; Cocco PL; Shanafelt TD; Call TG; Norman AD; Hanson C; Robinson D; Chaffee KG; Brooks-Wilson AR; Monnereau A; Clavel J; Glenn M; Curtin K; Conde L; Bracci PM; Morton LM; Cozen W; Severson RK; Chanock SJ; Spinelli JJ; Johnston JB; Rothman N; Skibola CF; Leis JF; Kay NE; Smedby KE; Berndt SI; Cerhan JR; Caporaso N; Slager SL
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2018;27(10):1809-1818

A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia

Chen X; Gustafsson S; Whitington T; Borne Y; Lorentzen E; Sun J; Almgren P; Su J; Karlsson R; Song J; Lu Y; Zhan Y; Hagg S; Svensson P; Smedby KE; Slager SL; Ingelsson E; Lindgren CM; Morris AP; Melander O; Karlsson T; de Faire U; Caidahl K; Engstrom G; Lind L; Karlsson MCI; Pedersen NL; Frostegard J; Magnusson PKE
Article: RADIOTHERAPY AND ONCOLOGY. 2018;126(3):424-430

Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register

Chen L; Eloranta S; Martling A; Glimelius I; Neovius M; Glimelius B; Smedby KE
Article: ACTA ONCOLOGICA. 2018;57(2):276-282

Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome

Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
Article: JOURNAL OF CROHNS & COLITIS. 2018;12(2):157-166

Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014

Nordenvall C; Rosvall O; Bottai M; Everhov AH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olen O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):88-97

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; Brown PDN; Enblad G; Amini R-M; Hjalgrim H; Glimelius I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):61-68

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013

Eloranta S; Branvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekstrom-Smedby K
Article: CANCER MEDICINE. 2018;7(1):114-122

Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI

Biccler J; Eloranta S; Brown PDN; Frederiksen H; Jerkeman M; Smedby KE; Bogsted M; El-Galaly TC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(36):4019-4026

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.

Maurer MJ; Ellin F; Srour L; Jerkeman M; Bennani NN; Connors JM; Slack GW; Smedby KE; Ansell SM; Link BK; Cerhan JR; Relander T; Savage KJ; Feldman AL
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;166(3):887-896

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy

Frisk G; Tinge B; Ekberg S; Eloranta S; Backlund LM; Lidbrink E; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(10):1159-1167

Parental Age and Risk of Lymphoid Neoplasms

Larfors G; Glimelius I; Eloranta S; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(7):1345-1354

Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma

Gordon D; Hansson J; Eloranta S; Gordon M; Gillgren P; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2017;109(10):djx041

Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients

He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K
Article: BMJ-BRITISH MEDICAL JOURNAL. 2017;358:j3951

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: CLINICAL CANCER RESEARCH. 2017;23(17):5292-5301

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton L-A; Minga E; Ntoufa S; Tausch E; Yan X-J; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc M-P; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Doehner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
Article: BLOOD ADVANCES. 2017;1(18):1427-1439

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander P; Kamper P; Smedby KE; Enblad G; Ludvigsen M; Mortensen J; Amini R-M; Hamilton-Dutoit S; d'Amore F; Molin D; Glimelius I
Journal article: CANCER RESEARCH. 2017;77(13_Supplement):1318

Abstract 1318: A genome-wide association study of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma demonstrates association with chromosome 6

McMaster ML; Berndt SI; Li SA; Slager S; Vijai J; Chung CC; Zhu B; Burdette L; Birmann B; Brown EE; Cerhan JR; Ekstrom-Smedby K; Hjalgrim H; Kleinstern G; Link BK; McKay J; Monnereau A; Morton LM; Nieters A; Rothman N; Skibola CF; Smith A; Teras LR; Vajdic CM; Vermeulen R; Hicks B; Goldin LR; Caporaso NE
Article: LEUKEMIA. 2017;31(7):1547-1554

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

Young E; Noerenberg D; Mansouri L; Ljungstrom V; Frick M; Sutton L-A; Blakemore SJ; Galan-Sousa J; Plevova K; Baliakas P; Rossi D; Clifford R; Roos-Weil D; Navrkalova V; Doerken B; Schmitt CA; Smedby KE; Juliusson G; Giacopelli B; Blachly JS; Belessi C; Panagiotidis P; Chiorazzi N; Davi F; Langerak AW; Oscier D; Schuh A; Gaidano G; Ghia P; Xu W; Fan L; Bernard OA; Nguyen-Khac F; Rassenti L; Li J; Kipps TJ; Stamatopoulos K; Pospisilova S; Zenz T; Oakes CC; Strefford JC; Rosenquist R; Damm F
Article: CANCER RESEARCH. 2017;77(13):3700-3707

Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma

Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):100-101

UNMET MEDICAL NEEDS IN HODGKIN LYMPHOMA WITH SPECIAL FOCUS ON THE ELDERLY – a POPULATION‐BASED STUDY OF PATIENTS DIAGNOSED IN SWEDEN 1973‐2014

Bjorkholm M; Weibull CE; Eloranta S; Ekström‐Smedby K; Glimelius I; Dickman PW
Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(14):1522-1529

Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality

Lu D; Ludvigsson JF; Smedby KE; Fall K; Valdimarsdottir U; Cnattingius S; Fang F
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma

Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708

Rheumatoid Arthritis and Risk of Malignant Lymphoma

Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
Article: SCIENTIFIC REPORTS. 2017;7(1):67

Patterns of acute inflammatory symptoms prior to cancer diagnosis

Setiawan A; Yin L; Auer G; Czene K; Smedby KE; Pawitan Y
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy

Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Article: NATURE COMMUNICATIONS. 2017;8:14175

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Law PJ; Berndt SI; Speedy HE; Camp NJ; Sava GP; Skibola CF; Holroyd A; Joseph V; Sunter NJ; Nieters A; Bea S; Monnereau A; Martin-Garcia D; Goldin LR; Clot G; Teras LR; Quintela I; Birmann BM; Jayne S; Cozen W; Majid A; Smedby KE; Lan Q; Dearden C; Brooks-Wilson AR; Hall AG; Purdue MP; Mainou-Fowler T; Vajdic CM; Jackson GH; Cocco P; Marr H; Zhang Y; Zheng T; Giles GG; Lawrence C; Call TG; Liebow M; Melbye M; Glimelius B; Mansouri L; Glenn M; Curtin K; Diver WR; Link BK; Conde L; Bracci PM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Boffetta P; Brennan P; Maynadie M; McKay J; Albanes D; Weinstein S; Wang Z; Caporaso NE; Morton LM; Severson RK; Riboli E; Vineis P; Vermeulen RCH; Southey MC; Milne RL; Clavel J; Topka S; Spinelli JJ; Kraft P; Ennas MG; Summerfield G; Ferri GM; Harris RJ; Miligi L; Pettitt AR; North KE; Allsup DJ; Fraumeni JFJ; Bailey JR; Offit K; Pratt G; Hjalgrim H; Pepper C; Chanock SJ; Fegan C; Rosenquist R; de Sanjose S; Carracedo A; Dyer MJS; Catovsky D; Campo E; Cerhan JR; Allan JM; Rothman N; Houlston R; Slager SL
Article: BRITISH JOURNAL OF SURGERY. 2017;104(3):278-287

Risk of second primary cancer in patients treated with radiotherapy for rectal cancer

Martling A; Smedby KE; Birgisson H; Olsson H; Granath F; Ekbom A; Glimelius B
Article: BMC GASTROENTEROLOGY. 2017;17(1):23

Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study

Ludvigsson JF; Busch K; Olen O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
Article: LUPUS SCIENCE & MEDICINE. 2017;4(1):e000187

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.

Bernatsky S; Velásquez García HA; Spinelli JJ; Gaffney P; Smedby KE; Ramsey-Goldman R; Wang SS; Adami H-O; Albanes D; Angelucci E; Ansell SM; Asmann YW; Becker N; Benavente Y; Berndt SI; Bertrand KA; Birmann BM; Boeing H; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Cerhan JR; Chanock SJ; Clavel J; Conde L; Cotenbader KH; Cox DG; Cozen W; Crouch S; De Roos AJ; de Sanjose S; Di Lollo S; Diver WR; Dogan A; Foretova L; Ghesquières H; Giles GG; Glimelius B; Habermann TM; Haioun C; Hartge P; Hjalgrim H; Holford TR; Holly EA; Jackson RD; Kaaks R; Kane E; Kelly RS; Klein RJ; Kraft P; Kricker A; Lan Q; Lawrence C; Liebow M; Lightfoot T; Link BK; Maynadie M; McKay J; Melbye M; Molina TJ; Monnereau A; Morton LM; Nieters A; North KE; Novak AJ; Offit K; Purdue MP; Rais M; Riby J; Roman E; Rothman N; Salles G; Severi G; Severson RK; Skibola CF; Slager SL; Smith A; Smith MT; Southey MC; Staines A; Teras LR; Thompson CA; Tilly H; Tinker LF; Tjonneland A; Turner J; Vajdic CM; Vermeulen RCH; Vijai J; Vineis P; Virtamo J; Wang Z; Weinstein S; Witzig TE; Zelenetz A; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Zucca M; Clarke AE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622

Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study

Melen CM; Enblad G; Sonnevi K; Junlen HR; Smedby KE; Jerkeman M; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(3):410-418

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

Eskelund CW; Kolstad A; Jerkeman M; Raty R; Laurell A; Eloranta S; Smedby KE; Husby S; Pedersen LB; Andersen NS; Eriksson M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundstrom C; Delabie J; Karjalainen-Lindsberg M-L; Workman CT; Garde C; Elonen E; Brown P; Gronbaek K; Geisler CH
Article: EPIGENETICS. 2016;11(6):449-455

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Bhoi S; Ljungstrom V; Baliakas P; Mattsson M; Smedby KE; Juliusson G; Rosenquist R; Mansouri L
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2016;45(3):728-740

Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

Khankhanian P; Cozen W; Himmelstein DS; Madireddy L; Din L; van den Berg A; Matsushita T; Glaser SL; Moré JM; Smedby KE; Baranzini SE; Mack TM; Lizée A; de Sanjosé S; Gourraud P-A; Nieters A; Hauser SL; Cocco P; Maynadié M; Foretová L; Staines A; Delahaye-Sourdeix M; Li D; Bhatia S; Melbye M; Onel K; Jarrett R; McKay JD; Oksenberg JR; Hjalgrim H
Article: GASTROENTEROLOGY. 2016;150(7):1561-1567.e1

Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study

Khalili H; Granath F; Smedby KE; Ekbom A; Neovius M; Chan AT; Olen O
Article: JOURNAL OF CANCER SURVIVORSHIP. 2016;10(3):514-523

Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse

Everhov AH; Ekberg S; Hirschberg AL; Bergmark K; Radestad AF; Glimelius I; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(6):987-994

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Chen L; Glimelius I; Neovius M; Ekberg S; Martling A; Eloranta S; Smedby KE
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;51(5):583-589

Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy

Mohammadi M; Song H; Cao Y; Glimelius I; Ekbom A; Ye W; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2016;25(8):1663-1676

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela MJ; Lan Q; Slager SL; Vermeulen RCH; Teras LR; Camp NJ; Cerhan JR; Spinelli JJ; Wang SS; Nieters A; Vijai J; Yeager M; Wang Z; Ghesquieres H; Mckay J; Conde L; de Bakker PIW; Cox DG; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Giles GG; Melbye M; Gu J; Jackson RD; Kane E; Purdue MP; Vajdic CM; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami H-O; Roos G; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; De Vivo I; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BCH; Liang L; Park J-H; Chung CC; Weisenburger DD; Fraumeni JFJ; Salles G; Glenn M; Cannon-Albright L; Curtin K; Wu X; Smedby KE; de Sanjose S; Skibola CF; Berndt SI; Birmann BM; Chanock SJ; Rothman N
Article: NATURE COMMUNICATIONS. 2016;7:10933

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Berndt SI; Camp NJ; Skibola CF; Vijai J; Wang Z; Gu J; Nieters A; Kelly RS; Smedby KE; Monnereau A; Cozen W; Cox A; Wang SS; Lan Q; Teras LR; Machado M; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Vajdic CM; Cocco P; Zhang Y; Giles GG; Zeleniuch-Jacquotte A; Lawrence C; Montalvan R; Burdett L; Hutchinson A; Ye Y; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Cunningham JM; Allmer C; Hjalgrim H; Adami H-O; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Arnett DK; Zhi D; Leach JM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Sala N; Casabonne D; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Chaffee KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Leis JF; Weinberg JB; Caporaso NE; Norman AD; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Masala G; Weiderpass E; Chirlaque M-D; Vermeulen RCH; Travis RC; Southey MC; Milne RL; Albanese D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Villano DJ; Maria A; Spinelli JJ; Gascoyne RD; Connors JM; Bertrand KA; Giovannucci E; Kraft P; Kricker A; Turner J; Ennas MG; Ferri GM; Miligi L; Liang L; Ma B; Huang J; Crouch S; Park J-H; Chatterjee N; North KE; Snowden JA; Wright J; Fraumeni JF; Offit K; Wu X; de Sanjose S; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Article: JOURNAL OF SEXUAL MEDICINE. 2016;13(3):413-424

Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study

Everhov AH; Radestad AF; Nyberg T; Smedby KE; Bergmark K; Hirschberg AL
Article: BLOOD. 2016;127(8):1007-1016

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungstrom V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton L-A; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Hoglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjoblom T; Rosenquist R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344

Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma

Weibull CE; Eloranta S; Smedby KE; Bjorkholm M; Kristinsson SY; Johansson ALV; Dickman PW; Glimelius I
Article: BRITISH JOURNAL OF DERMATOLOGY. 2016;174(1):95-103

Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study

Krynitz B; Olsson H; Rozell BL; Lindelof B; Edgren G; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(12):djv279

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Sampson JN; Wheeler WA; Yeager M; Panagiotou O; Wang Z; Berndt SI; Lan Q; Abnet CC; Amundadottir LT; Figueroa JD; Landi MT; Mirabello L; Savage SA; Taylor PR; De Vivo I; McGlynn KA; Purdue MP; Rajaraman P; Adami H-O; Ahlbom A; Albanes D; Amary MF; An S-J; Andersson U; Andriole GJ; Andrulis IL; Angelucci E; Ansell SM; Arici C; Armstrong BK; Arslan AA; Austin MA; Baris D; Barkauskas DA; Bassig BA; Becker N; Benavente Y; Benhamou S; Berg C; Van Den Berg D; Bernstein L; Bertrand KA; Birmann BM; Black A; Boeing H; Boffetta P; Boutron-Ruault M-C; Bracci PM; Brinton L; Brooks-Wilson AR; Bueno-de-Mesquita HB; Burdett L; Buring J; Butler MA; Cai Q; Cancel-Tassin G; Canzian F; Carrato A; Carreon T; Carta A; Chan JKC; Chang ET; Chang G-C; Chang I-S; Chang J; Chang-Claude J; Chen C-J; Chen C-Y; Chen C; Chen C-H; Chen C; Chen H; Chen K; Chen K-Y; Chen K-C; Chen Y; Chen Y-H; Chen Y-S; Chen Y-M; Chien L-H; Chirlaque M-D; Choi JE; Choi YY; Chow W-H; Chung CC; Clavel J; Clavel-Chapelon F; Cocco P; Colt JS; Comperat E; Conde L; Connors JM; Conti D; Cortessis VK; Cotterchio M; Cozen W; Crouch S; Crous-Bou M; Cussenot O; Davis FG; Ding T; Diver WR; Dorronsoro M; Dossus L; Duell EJ; Ennas MG; Erickson RL; Feychting M; Flanagan AM; Foretova L; Fraumeni JFJ; Freedman ND; Freeman LEB; Fuchs C; Gago-Dominguez M; Gallinger S; Gao Y-T; Gapstur SM; Garcia-Closas M; Garcia-Closas R; Gascoyne RD; Gastier-Foster J; Gaudet MM; Gaziano JM; Giffen C; Giles GG; Giovannucci E; Glimelius B; Goggins M; Gokgoz N; Goldstein AM; Gorlick R; Gross M; Grubb RIII; Gu J; Guan P; Gunter M; Guo H; Habermann TM; Haiman CA; Halai D; Hallmans G; Hassan M; Hattinger C; He Q; He X; Helzlsouer K; Henderson B; Henriksson R; Hjalgrim H; Hoffman-Bolton J; Hohensee C; Holford TR; Holly EA; Hong Y-C; Hoover RN; Horn-Ross PL; Hosain GMM; Hosgood HDIII; Hsiao C-F; Hu N; Hu W; Hu Z; Huang M-S; Huerta J-M; Hung J-Y; Hutchinson A; Inskip PD; Jackson RD; Jacobs EJ; Jenab M; Jeon H-S; Ji B-T; Jin G; Jin L; Johansen C; Johnson A; Jung YJ; Kaaks R; Kamineni A; Kane E; Kang CH; Karagas MR; Kelly RS; Khaw K-T; Kim C; Kim HN; Kim JH; Kim JS; Kim YH; Kim YT; Kim Y-C; Kitahara CM; Klein AP; Klein RJ; Kogevinas M; Kohno T; Kolonel LN; Kooperberg C; Kricker A; Krogh V; Kunitoh H; Kurtz RC; Kweon S-S; LaCroix A; Lawrence C; Lecanda F; Lee VHF; Li D; Li H; Li J; Li Y-J; Li Y; Liao LM; Liebow M; Lightfoot T; Lim W-Y; Lin C-C; Lin D; Lindstrom S; Linet MS; Link BK; Liu C; Liu J; Liu L; Ljungberg B; Lloreta J; Di Lollo S; Lu D; Lund E; Malats N; Mannisto S; Le Marchand L; Marina N; Masala G; Mastrangelo G; Matsuo K; Maynadie M; Mckay J; McKean-Cowdin R; Melbye M; Melin BS; Michaud DS; Mitsudomi T; Monnereau A; Montalvan R; Moore LE; Mortensen LM; Nieters A; North KE; Novak AJ; Oberg AL; Offit K; Oh I-J; Olson SH; Palli D; Pao W; Park IK; Park JY; Park KH; Patino-Garcia A; Pavanello S; Peeters PHM; Perng R-P; Peters U; Petersen GM; Picci P; Pike MC; Porru S; Prescott J; Prokunina-Olsson L; Qian B; Qiao Y-L; Rais M; Riboli E; Riby J; Risch HA; Rizzato C; Rodabough R; Roman E; Roupret M; Ruder AM; de Sanjose S; Scelo G; Schned A; Schumacher F; Schwartz K; Schwenn M; Scotlandi K; Seow A; Serra C; Serra M; Sesso HD; Setiawan VW; Severi G; Severson RK; Shanafelt TD; Shen H; Shen W; Shin M-H; Shiraishi K; Shu X-O; Siddiq A; Sierrasesumaga L; Sihoe ADL; Skibola CF; Smith A; Smith MT; Southey MC; Spinelli JJ; Staines A; Stampfer M; Stern MC; Stevens VL; Stolzenberg-Solomon RS; Su J; Su W-C; Sund M; Sung JS; Sung SW; Tan W; Tang W; Tardon A; Thomas D; Thompson CA; Tinker LF; Tirabosco R; Tjonneland A; Travis RC; Trichopoulos D; Tsai F-Y; Tsai Y-H; Tucker M; Turner J; Vajdic CM; Vermeulen RCH; Villano DJ; Vineis P; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Wang C-L; Wang J-C; Wang J; Wei F; Weiderpass E; Weiner GJ; Weinstein S; Wentzensen N; White E; Witzig TE; Wolpin BM; Wong MP; Wu C; Wu G; Wu J; Wu T; Wu W; Wu X; Wu Y-L; Wunder JS; Xiang Y-B; Xu J; Xu P; Yang P-C; Yang T-Y; Ye Y; Yin Z; Yokota J; Yoon H-I; Yu C-J; Yu H; Yu K; Yuan J-M; Zelenetz A; Zeleniuch-Jacquotte A; Zhang X-C; Zhang Y; Zhao X; Zhao Z; Zheng H; Zheng T; Zheng W; Zhou B; Zhu M; Zucca M; Boca SM; Cerhan JR; Ferri GM; Hartge P; Hsiung CA; Magnani C; Miligi L; Morton LM; Smedby KE; Teras LR; Vijai J; Wang SS; Brennan P; Caporaso NE; Hunter DJ; Kraft P; Rothman N; Silverman DT; Slager SL; Chanock SJ; Chatterjee N
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(12):1838-1843

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma

Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadie M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjose S; Lathrop M; Melbye M; Brennan P; Diepstra A; Van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics

Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
Article: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):599-609

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study

Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Article: ACTA ONCOLOGICA. 2015;54(10):1770-1780

Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment

Nord C; Olofsson S-E; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Stahl E; Neovius M; Jerkeman M; Smedby KE
Article: BMC CANCER. 2015;15:850

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study

Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
Article: EUROPEAN JOURNAL OF CANCER PREVENTION. 2015;24(6):535-541

Maternal and birth anthropometric characteristics in relation to the risk of childhood lymphomas: a Swedish nationwide cohort study

Petridou ET; Sergentanis TN; Skalkidou A; Antonopoulos CN; Dessypris N; Svensson T; Stephansson O; Kieler H; Smedby KE
Article: COLORECTAL DISEASE. 2015;17(10):882-890

Probability, rate and timing of reconstructive surgery following colectomy for inflammatory bowel disease in Sweden: a population-based cohort study

Nordenvall C; Myrelid P; Ekbom A; Bottai M; Smedby KE; Olen O; Nilsson PJ
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;182(7):624-632

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini R-M; Brown PDN; Glimelius B; Adami H-O; Melbye M; Glimelius I; Hjalgrim H
Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432

Risk of disability pension in patients following rectal cancer treatment and surgery

Chen L; Glimelius I; Neovius M; Eloranta S; Ekberg S; Martling A; Smedby KE
Article: MELANOMA RESEARCH. 2015;25(4):348-356

Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study

Gordon D; Gillgren P; Eloranta S; Olsson H; Gordon M; Hansson J; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(7):1061-1070

Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.

Kane E; Skibola CF; Bracci PM; Cerhan JR; Costas L; Smedby KE; Holly EA; Maynadié M; Novak AJ; Lightfoot TJ; Ansell SM; Smith AG; Liebow M; Melbye M; Morton L; de Sanjosé S; Slager SL; Wang SS; Zhang Y; Zheng T; Roman E
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2015;73(1):106-113.e2

Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality

Krynitz B; Rozell BL; Lyth J; Smedby KE; Lindelof B
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2015;212(6):833-843

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

Mansouri L; Sutton L-A; Ljungstrom V; Bondza S; Arngarden L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sorqvist E; Lonn P; Muggen AF; Yan X-J; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellstrom M; Jernberg-Wiklund H; Ghia P; Soderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
Article: MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 2015;22(6):633-639

Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study

Everhov AH; Nyberg T; Bergmark K; Citarella A; Radestad AF; Hirschberg AL; Smedby KE
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(6):751-757

Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis

Pawitan Y; Yin L; Setiawan A; Auer G; Smedby KE; Czene K
Article: JOURNAL OF RHEUMATOLOGY. 2015;42(4):690-694

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight A; Hjorton K; Sundstrom C; Hoglund M; Backlin C; Smedby KE; Askling J; Baecklund E
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;181(6):406-421

Associations of Non-Hodgkin Lymphoma (NHL) Risk With Autoimmune Conditions According to Putative NHL Loci

Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcon GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Article: LEUKEMIA. 2015;29(2):329-336

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas P; Hadzidimitriou A; Sutton L-A; Rossi D; Minga E; Villamor N; Larrayoz M; Kminkova J; Agathangelidis A; Davis Z; Tausch E; Stalika E; Kantorova B; Mansouri L; Scarfo L; Cortese D; Navrkalova V; Rose-Zerilli MJJ; Smedby KE; Juliusson G; Anagnostopoulos A; Makris AM; Navarro A; Delgado J; Oscier D; Belessi C; Stilgenbauer S; Ghia P; Pospisilova S; Gaidano G; Campo E; Strefford JC; Stamatopoulos K; Rosenquist R
Article: BLOOD. 2015;125(5):856-859

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Baliakas P; Agathangelidis A; Hadzidimitriou A; Sutton L-A; Minga E; Tsanousa A; Scarfo L; Davis Z; Yan X-J; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; Moreno D; Van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc M-P; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
Article: NATURE COMMUNICATIONS. 2015;6:5751

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai J; Wang Z; Berndt SI; Skibola CF; Slager SL; de Sanjose S; Melbye M; Glimelius B; Bracci PM; Conde L; Birmann BM; Wang SS; Brooks-Wilson AR; Lan Q; de Bakker PIW; Vermeulen RCH; Portlock C; Ansell SM; Link BK; Riby J; North KE; Gu J; Hjalgrim H; Cozen W; Becker N; Teras LR; Spinelli JJ; Turner J; Zhang Y; Purdue MP; Giles GG; Kelly RS; Zeleniuch-Jacquotte A; Ennas MG; Monnereau A; Bertrand KA; Albanes D; Lightfoot T; Yeager M; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Villano DJ; Maria A; Corines M; Thomas T; Novak AJ; Dogan A; Liebow M; Thompson CA; Witzig TE; Habermann TM; Weiner GJ; Smith MT; Holly EA; Jackson RD; Tinker LF; Ye Y; Adami H-O; Smedby KE; De Roos AJ; Hartge P; Morton LM; Severson RK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Mckay J; Staines A; Diver WR; Vajdic CM; Armstrong BK; Kricker A; Zheng T; Holford TR; Severi G; Vineis P; Ferri GM; Ricco R; Miligi L; Clavel J; Giovannucci E; Kraft P; Virtamo J; Smith A; Kane E; Roman E; Chiu BCH; Fraumeni JF; Wu X; Cerhan JR; Offit K; Chanock SJ; Rothman N; Nieters A
Article: TRANSLATIONAL ONCOLOGY. 2014;7(6):732-740

High Prevalence of Human Cytomegalovirus in Brain Metastases of Patients with Primary Breast and Colorectal Cancers

Taher C; Frisk G; Fuentes S; Religa P; Costa H; Assinger A; Vetvik KK; Bukholm IRK; Yaiw K-C; Smedby KE; Backlund M; Soderberg-Naucler C; Rahbar A
Article: NATURE GENETICS. 2014;46(11):1233-1238

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Cerhan JR; Berndt SI; Vijai J; Ghesquieres H; McKay J; Wang SS; Wang Z; Yeager M; Conde L; de Bakker PIW; Nieters A; Cox D; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Lan Q; Severi G; Melbye M; Gu J; Jackson RD; Kane E; Teras LR; Purdue MP; Vajdic CM; Spinelli JJ; Giles GG; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Weiner GJ; Veron AS; Zelenika D; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami H-O; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Kricker A; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Vermeulen RCH; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; Birmann BM; Laden F; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BCH; Sampson J; Liang L; Park J-H; Chung CC; Weisenburger DD; Chatterjee N; Fraumeni JFJ; Slager SL; Wu X; de Sanjose S; Smedby KE; Salles G; Skibola CF; Rothman N; Chanock SJ
Article: PSYCHO-ONCOLOGY. 2014;23(11):1276-1282

Risk and predictors of attempted and completed suicide in patients with hematological malignancies

Mohammadi M; Moradi T; Bottai M; Reutfors J; Cao Y; Smedby KE
Article: LANCET HAEMATOLOGY. 2014;1(2):E74-E84

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Baliakas P; Hadzidimitriou A; Sutton L-A; Minga E; Agathangelidis A; Nichelatti M; Tsanousa A; Scarfo L; Davis Z; Yan X-J; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc M-P; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Rosenquist R; Ghia P; Stamatopoulos K
Article: BMC MEDICAL GENETICS. 2014;15:113

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

Baecklund F; Foo J-N; Bracci P; Darabi H; Karlsson R; Hjalgrim H; Rosenquist R; Adami H-O; Glimelius B; Melbye M; Conde L; Liu J; Humphreys K; Skibola CF; Smedby KE
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2014;95(4):462-471

Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

Skibola CF; Berndt SI; Vijai J; Conde L; Wang Z; Yeager M; de Bakker PIW; Birmann BM; Vajdic CM; Foo J-N; Bracci PM; Vermeulen RCH; Slager SL; de Sanjose S; Wang SS; Linet MS; Salles G; Lan Q; Severi G; Hjalgrim H; Lightfoot T; Melbye M; Gu J; Ghesquieres H; Link BK; Morton LM; Holly EA; Smith A; Tinker LF; Teras LR; Kricker A; Becker N; Purdue MP; Spinelli JJ; Zhang Y; Giles GG; Vineis P; Monnereau A; Bertrand KA; Albanes D; Zeleniuch-Jacquotte A; Gabbas A; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Liu J; Adami H-O; Glimelius B; Ye Y; Nowakowski GS; Dogan A; Thompson CA; Habermann TM; Novak AJ; Liebow M; Witzig TE; Weiner GJ; Schenk M; Hartge P; De Roos AJ; Cozen W; Zhi D; Akers NK; Riby J; Smith MT; Lacher M; Villano DJ; Maria A; Roman E; Kane E; Jackson RD; North KE; Diver WR; Turner J; Armstrong BK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; McKay J; Brooks-Wilson AR; Zheng T; Holford TR; Chamosa S; Kaaks R; Kelly RS; Ohlsson B; Travis RC; Weiderpass E; Clave J; Giovannucci E; Kraft P; Virtamo J; Mazza P; Cocco P; Ennas MG; Chiu BCH; Fraumeni JRJ; Nieters A; Offit K; Wu X; Cerhan JR; Smedby KE; Chanock SJ; Rothman N
Article: ANNALS OF SURGICAL ONCOLOGY. 2014;21(11):3386-3394

Sentinel Node Location in Trunk and Extremity Melanomas: Uncommon or Multiple Lymph Drainage Does Not Affect Survival

Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2014;93(9):949-953

Anti-Mullerian hormone in premenopausal women following treatment of uterine cervical cancer

Everhov AH; Bergmark K; Smedby KE; Hirschberg AL; Radestad AF
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):130-144

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BCH; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami H-O; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):76-86

Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Smedby KE; Sampson JN; Turner JJ; Slager SL; Maynadié M; Roman E; Habermann TM; Flowers CR; Berndt SI; Bracci PM; Hjalgrim H; Weisenburger DD; Morton LM
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):52-65

Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BCH; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):1-14

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BCH; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2014;40(3):280-287

Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study

Nordenvall C; Ekbom A; Bottai M; Smedby KE; Nilsson PJ
Article: NATURE COMMUNICATIONS. 2014;5:3856

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen W; Timofeeva MN; Li D; Diepstra A; Hazelett D; Delahaye-Sourdeix M; Edlund CK; Franke L; Rostgaard K; Van Den Berg DJ; Cortessis VK; Smedby KE; Glaser SL; Westra H-J; Robison LL; Mack TM; Ghesquieres H; Hwang AE; Nieters A; de Sanjose S; Lightfoot T; Becker N; Maynadie M; Foretova L; Roman E; Benavente Y; Rand KA; Nathwani BN; Glimelius B; Staines A; Boffetta P; Link BK; Kiemeney L; Ansell SM; Bhatia S; Strong LC; Galan P; Vatten L; Habermann TM; Duell EJ; Lake A; Veenstra RN; Visser L; Liu Y; Urayama KY; Montgomery D; Gaborieau V; Weiss LM; Byrnes G; Lathrop M; Cocco P; Best T; Skol AD; Adami H-O; Melbye M; Cerhan JR; Gallagher A; Taylor GM; Slager SL; Brennan P; Coetzee GA; Conti DV; Onel K; Jarrett RF; Hjalgrim H; van den Berg A; Mckay JD
Article: BMC CANCER. 2014;14:391

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden

Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
Article: LEUKEMIA RESEARCH. 2014;38(6):682-690

Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays

Pauly F; Smedby KE; Jerkeman M; Hjalgrim H; Ohlsson M; Rosenquist R; Borrebaeck CAK; Wingren C
Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290

Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2014;39(1):57-68

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study

Busch K; Ludvigsson JF; Ekstrom-Smedby K; Ekbom A; Askling J; Neovius M
Article: NATURE GENETICS. 2014;46(1):56-60

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Speedy HE; Di Bernardo MC; Sava GP; Dyer MJS; Holroyd A; Wang Y; Sunter NJ; Mansouri L; Juliusson G; Smedby KE; Roos G; Jayne S; Majid A; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Article: BLOOD. 2013;122(20):3492-3499

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis

Monnereau A; Glaser SL; Schupp CW; Smedby KE; de Sanjosé S; Kane E; Melbye M; Forétova L; Maynadié M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Glimelius I; Clavel J; Hjalgrim H; Chang ET
Article: BRITISH JOURNAL OF CANCER. 2013;109(7):1921-1925

Low-dose aspirin use and cancer characteristics: a population-based cohort study

Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Article: TRANSPLANTATION. 2013;96(3):297-305

Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History

Brattstrom C; Granath F; Edgren G; Smedby KE; Wilczek HE
Article: ANNALS OF INTERNAL MEDICINE. 2013;159(3):169-175

Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease A Population-Based Cohort Study

Lebwohl B; Granath F; Ekbom A; Smedby KE; Murray JA; Neugut AI; Green PHR; Ludvigsson JF
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(8):647-651

Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients

Mansouri L; Grabowski P; Degerman S; Svenson U; Gunnarsson R; Cahill N; Smedby KE; Geisler C; Juliusson G; Roos G; Rosenquist R
Article: NATURE GENETICS. 2013;45(8):868-876

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Berndt SI; Skibola CF; Joseph V; Camp NJ; Nieters A; Wang Z; Cozen W; Monnereau A; Wang SS; Kelly RS; Lan Q; Teras LR; Chatterjee N; Chung CC; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Armstrong BK; Cocco P; Zhang Y; Severi G; Zeleniuch-Jacquotte A; Lawrence C; Burdette L; Yuenger J; Hutchinson A; Jacobs KB; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Wang AH; Smedby KE; Adami H-O; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Jones B; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Holly EA; Smith MT; Jackson RD; Tinker LF; Benavente Y; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Leis JF; Cunningham JM; Weinberg JB; Morrison VA; Caporaso NE; Norman AD; Linet MS; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Masala G; Weiderpass E; Chirlaque M-D; Vermeulen RCH; Travis RC; Giles GG; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Offit K; Zelenetz A; Klein RJ; Spinelli JJ; Bertrand KA; Laden F; Giovannucci E; Kraft P; Kricker A; Turner J; Vajdic CM; Ennas MG; Ferri GM; Miligi L; Liang L; Sampson J; Crouch S; Park J-H; North KE; Cox A; Snowden JA; Wright J; Carracedo A; Lopez-Otin C; Bea S; Salaverria I; Martin-Garcia D; Campo E; Fraumeni JFJ; de Sanjose S; Hjalgrim H; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2013;93(1):167-172

Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk

Foo JN; Smedby KE; Akers NK; Berglund M; Irwan ID; Jia X; Li Y; Conde L; Darabi H; Bracci PM; Melbye M; Adami H-O; Glimelius B; Khor CC; Hjalgrim H; Padyukov L; Humphreys K; Enblad G; Skibola CF; de Bakker PIW; Liu J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(2):221-228

rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?

Sava GP; Speedy HE; Di Bernardo MC; Deaglio S; Karabon L; Frydecka I; Woszczyk D; Rossi D; Gaidano G; Mansouri L; Smedby KE; Juliusson G; Rosenquist R; Catovsky D; Houlston RS
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(11):2659-2666

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Simard JF; Baecklund F; Chang ET; Baecklund E; Hjalgrim H; Adami H-O; Glimelius B; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(6):1429-1438

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-A Swedish population-based study

Krynitz B; Edgren G; Lindelof B; Baecklund E; Brattstrom C; Wilczek H; Smedby KE
Article: GASTROENTEROLOGY. 2013;144(3):536-543

Patients With Ulcerative Colitis Miss More Days of Work Than the General Population, Even Following Colectomy

Neovius M; Arkema EV; Blomqvist P; Ekbom A; Smedby KE
Article: LAKARTIDNINGEN. 2013;110(3):81

["Tools for clinical research"--a new series of articles in Läkartidningen].

Smedby KE; Lagerros YT
Article: PLOS ONE. 2013;8(9):e74619

Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.

Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
Article: CANCER CAUSES & CONTROL. 2013;24(1):125-134

Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium

Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjose S; Vajdic CM; Zhang Y; Chiu BC-H; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Article: LEUKEMIA. 2013;27(1):150-158

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments

Cahill N; Bergh A-C; Kanduri M; Goransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundstrom C; Rosen A; Rosenquist R
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(10):2342-2348

Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis

Becker N; Falster MO; Vajdic CM; de Sanjose S; Martinez-Maza O; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Costantini AS; Holly EA; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC-H; Montella M; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Cozen W; Grulich AE; Newton R
Article: ACTA DERMATO-VENEREOLOGICA. 2012;92(6):609-614

No Association between Infections, HLA Type and Other Transplant-related Factors and Risk of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients

Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
Article: BMC GENOMICS. 2012;13:516

A meta-analysis of genome-wide association studies of follicular lymphoma

Skibola CF; Conde L; Foo J-N; Riby J; Humphreys K; Sille FCM; Darabi H; Sanchez S; Hjalgrim H; Liu J; Bracci PM; Smedby KE
Article: HISTOPATHOLOGY. 2012;61(1):26-32

Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma

Glimelius I; Qvarnstrom F; Simonsson M; Ekwall A; Smedby KE; Molin D; Amini R-M
Article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2012;12(3):201-206

IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Cahill N; Sutton L-A; Jansson M; Murray F; Mansouri L; Gunnarsson R; Ryan F; Smedby KE; Geisler C; Juliusson G; Rosenquist R
Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1850-1853

Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden

Frisk G; Svensson T; Backlund LM; Lidbrink E; Blomqvist P; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2012;104(3):240-253

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups

Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadie M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini R-M; Adami H-O; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjonneland A; Melin B; Canzian F; Khaw K-T; Travis RC; Peeters PHM; Gonzalez CA; Quiros JR; Sanchez M-J; Maria Huerta J; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjose S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2011;11(11):2472-2482

Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients

Fernberg P; Edgren G; Adami J; Ingvar A; Bellocco R; Tufveson G; Hoglund P; Kinch A; Simard JF; Baecklund E; Lindelof B; Pawitan Y; Smedby KE
Article: DIGESTIVE AND LIVER DISEASE. 2011;43(11):862-868

Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype

Olen O; Askling J; Ludvigsson JF; Hildebrand H; Ekbom A; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(3):208-216

Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma - a population-based study

Glimelius I; Rubin J; Rostgaard K; Amini R-M; Simonsson M; Sorensen KM; Smedby KE; Venge P; Hjalgrim H; Molin D; Enblad G
Article: HAEMATOLOGICA. 2011;96(8):1161-1169

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

Gunnarsson R; Mansouri L; Isaksson A; Goransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Article: HAEMATOLOGICA. 2011;96(8):1153-1160

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia

Kaderi MA; Kanduri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Jurlander J; Juliusson G; Mansouri L; Rosenquist R
Article: PLOS GENETICS. 2011;7(4):e1001378

GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami H-O; Humphreys K; Liu J
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011;103(5):436-444

Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease

Elfstrom P; Granath F; Smedby KE; Montgomery SM; Askling J; Ekbom A; Ludvigsson JF
Article: LEUKEMIA RESEARCH. 2011;35(2):272-274

TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

Zainuddin N; Murray F; Kanduri M; Gunnarsson R; Smedby KE; Enblad G; Jurlander J; Juliusson G; Rosenquist R
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2011;11(1):146-151

Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

Simard JF; Baecklund E; Kinch A; Brattstrom C; Ingvar A; Molin D; Adami J; Fernberge P; Wilczek H; Ekbom A; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2011;173(1):48-54

Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of Non-Hodgkin Lymphoma

Smedby KE; Eloranta S; Duvefelt K; Melbye M; Humphreys K; Hjalgrim H; Chang ET
Article: NATURE GENETICS. 2010;42(12):1126-1130

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Enciso-Mora V; Broderick P; Ma Y; Jarrett RF; Hjalgrim H; Hemminki K; van den Berg A; Olver B; Lloyd A; Dobbins SE; Lightfoot T; van Leeuwen FE; Foersti A; Diepstra A; Broeks A; Vijayakrishnan J; Shield L; Lake A; Montgomery D; Roman E; Engert A; von Strandmann EP; Reiners KS; Nolte IM; Smedby KE; Adami H-O; Russell NS; Glimelius B; Hamilton-Dutoit S; de Bruin M; Ryder LP; Molin D; Sorensen KM; Chang ET; Taylor M; Cooke R; Hofstra R; Westers H; van Wezel T; van Eijk R; Ashworth A; Rostgaard K; Melbye M; Swerdlow AJ; Houlston RS
Article: HAEMATOLOGICA. 2010;95(12):2072-2079

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors

Marincevic M; Mansouri M; Kanduri M; Isaksson A; Goransson H; Smedby KE; Jurlander J; Juliusson G; Davi F; Stamatopoulos K; Rosenquist R
Article: NATURE GENETICS. 2010;42(8):661-664

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

Conde L; Halperin E; Akers NK; Brown KM; Smedby KE; Rothman N; Nieters A; Slager SL; Brooks-Wilson A; Agana L; Riby J; Liu J; Adami H-O; Darabi H; Hjalgrim H; Low H-Q; Humphreys K; Melbye M; Chang ET; Glimelius B; Cozen W; Davis S; Hartge P; Morton LM; Schenk M; Wang SS; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Becker N; Benavente Y; Boffetta P; Brennan P; Butterbach K; Cocco P; Foretova L; Maynadie M; de Sanjose S; Staines A; Spinelli JJ; Achenbach SJ; Call TG; Camp NJ; Glenn M; Caporaso NE; Cerhan JR; Cunningham JM; Goldin LR; Hanson CA; Kay NE; Lanasa MC; Leis JF; Marti GE; Rabe KG; Rassenti LZ; Spector LG; Strom SS; Vachon CM; Weinberg JB; Holly EA; Chanock S; Smith MT; Bracci PM; Skibola CF
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(8):2764-2771

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma

Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;150(4):473-479

Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk

Crowther-Swanepoel D; Mansouri M; Enjuanes A; Vega A; Smedby KE; Ruiz-Ponte C; Jurlander J; Juliusson G; Montserrat E; Catovsky D; Campo E; Carracedo A; Rosenquist R; Houlston RS
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(6):1569-1576

Pigmentary Characteristics, UV Radiation Exposure, and Risk of Non-Hodgkin Lymphoma: a Prospective Study among Scandinavian Women

Veierod MB; Smedby KE; Lund E; Adami H-O; Weiderpass E
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258

Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis

Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Article: CANCER CAUSES & CONTROL. 2010;21(5):759-769

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma

Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sorensen KM; Porwit A; Humphreys K; Melbye M; Smedby KE
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(14):6400-6405

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Hjalgrim H; Rostgaard K; Johnson PCD; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami H-O; Glimelius B; Hamilton-Dutoit S; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander FE; Melbye M; Jarrett RF
Article: NATURE GENETICS. 2010;42(2):132-136

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

Crowther-Swanepoel D; Broderick P; Di Bernardo MC; Dobbins SE; Torres M; Mansouri M; Ruiz-Ponte C; Enjuanes A; Rosenquist R; Carracedo A; Jurlander J; Campo E; Juliusson G; Montserrat E; Smedby KE; Dyer MJS; Matutes E; Dearden C; Sunter NJ; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Parker A; Oscier D; Allan JM; Catovsky D; Houlston RS
Article: BRITISH JOURNAL OF CANCER. 2009;101(11):1919-1924

Brain metastases admissions in Sweden between 1987 and 2006

Smedby KE; Brandt L; Backlund ML; Blomqvist P
Journal article: BLOOD. 2009;114(22):269

Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis.

Jarrett R; Johnson PC; Rostgaard K; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami HO; Glimelius B; Dutoit SH; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander F; Melbye M; Hjalgrim H
Article: CANCER RESEARCH. 2009;69(16):6482-6489

Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis

Vajdic CM; Falster MO; de Sanjose S; Martinez-Maza O; Becker N; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Costantini AS; Holly EA; Kane E; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC-H; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Cozen W; Grulich AE
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(11):2616-2620

Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

Biggar RJ; Christiansen M; Rostgaard K; Smedby KE; Adami H-O; Glimelius B; Hjalgrim H; Melbye M
Article: CLINICAL CANCER RESEARCH. 2008;14(21):6974-6978

Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

Biggar RJ; Johansen JS; Smedby KE; Rostgaard K; Chang ET; Adami H-O; Glimelius B; Molin D; Hamilton-Dutoit S; Melbye M; Hjalgrim H
Article: GENES CHROMOSOMES & CANCER. 2008;47(8):697-711

Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia -: A comparative study of four differently designed, high resolution Microarray platforms

Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Goransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hialgrim H; Syvanen A-C; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
Article: BLOOD. 2008;111(12):5524-5529

Borrelia infection and risk of non-Hodgkin lymphoma

Schollkopf C; Melbye M; Munksgaard L; Smedby KE; Rostgaard K; Glimelius B; Chang ET; Roos G; Hansen M; Adami H-O; Hjalgrim H
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(9):2062-2070

Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph consortium

Willett EV; Morton LM; Hartge P; Becker N; Bernstein L; Boffetta P; Bracci P; Cerhan J; Chiu BC-H; Cocco P; Dal Maso L; Davis S; De Sanjose S; Smedby KE; Ennas MG; Foretova L; Holiy EA; La Vecchia C; Matsuo K; Maynadie M; Melbye M; Negri E; Nieters A; Severson R; Slager SL; Spinelli JJ; Staines A; Talamini R; Vornanen M; Weisenburger DD; Roman E
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(8):1885-1890

Hepatitis C infection and risk of malignant lymphoma

Schoellkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundstroem C; Hansen M; Adami H-O; Melbye M
Article: BLOOD. 2008;111(8):4029-4038

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium

Smedby KE; Vajdic CM; Falster M; Engels EA; Martinez-Maza O; Turner J; Hjalgrim H; Vineis P; Costantini AS; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjose S; Chiu BC-H; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(1):144-154

Personal sun exposure and risk of non Hodgkin lymphoma:: A pooled analysis from the Interlymph Consortium

Kricker A; Armstrong BK; Hughes AM; Goumas C; Smedby KE; Zheng T; Spinelli JJ; De Sanjose S; Hartge P; Melbye M; Willett EV; Becker N; Chiu BCH; Cerhan JR; Maynadie M; Staines A; Cocco P; Boffeta P
Article: CANCER RESEARCH. 2007;67(22):11074-11082

Childhood social environment and risk of non-hodgkin lymphoma in adults

Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami H-O; Melbye M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007;16(8):1561-1566

Cigarette smoking and risk of Hodgkin lymphoma:: A population-based case-control study

Hjalgrim H; Ekstrom-Smedby K; Rostgaard K; Amini R-M; Molin D; Hamilton-Dutoit S; Schollkopf C; Chang ET; Ralfkiaer E; Adami H-O; Glimelius B; Melbye M
Article: CANCER RESEARCH. 2007;67(5):2382-2388

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundstrom C; Adami H-O; Glimelius B; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2007;99(2):158-166

Atopy and risk of non-Hodgkin lymphoma

Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schollkopf C; Sundstrom C; Chang ET; Koskela P; Adami H-O; Hjalgrim H
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2006;164(12):1222-1232

Nutrient intake and risk of non-Hodgkin's lymphoma

Chang ET; Balter KM; Torrang A; Smedby KE; Melbye M; Sundstrom C; Glimelius B; Adami H-O
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(2):258-265

Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma

Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):61-68

Reliability of self-reported family history of cancer in a large case-control study of lymphoma

Chang ET; Smedby KE; Hjalgrim H; Glimelius B; Adami HO
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):51-60

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Smedby KE; Hjalgrim H; Askling J; T Chang E; Gregersen H; Porwit-MacDonald A; Sundström C; Åkerman M; Melbye M; Glimelius B; Adami HO
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2005;162(10):965-974

Medication use and risk of non-Hodgkin's lymphoma

Chang ET; Smedby KE; Hjalgrim H; Schöllkopf C; Porwit-MacDonald A; Sundström C; Tani E; d'Amore F; Melbye M; Adami HO; Glimelius B
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(19):1466-1474

Family history of hematopoietic malignancy and risk of lymphoma

Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2005;14(7):1791-1796

Cigarette smoking and risk of non-hodgkin's lymphoma -: A population-based case-control study

Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Gadeberg O; Roos G; Porwit-MacDonald A; Glimelius B; Adami HO; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(3):210-218

Body mass index and risk of malignant lymphoma in Scandinavian men and women

Chang ET; Hjalgrim H; Smedby KE; Åkerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(3):199-209

Ultraviolet radiation exposure and risk of malignant lymphomas

Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2005;14(2):512-520

Dietary factors and risk of non-Hodgkin lymphoma in men and women

Chang ET; Smedby KE; Zhang SM; Hjalgrim H; Melbye M; Öst Å; Glimelius B; Wolk A; Adami HO
Article: GUT. 2005;54(1):54-59

Malignant lymphomas in coeliac disease:: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

Smedby KE; Åkerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
Article: CANCER CAUSES & CONTROL. 2004;15(10):1067-1076

Alcohol intake and risk of non-Hodgkin lymphoma in men and women

Chang ET; Smedby KE; Zhang SM; Hjalgrim H; Melbye M; Öst A; Wolk A; Adami HO; Glimelius B
Article: BRITISH JOURNAL OF CANCER. 2003;89(7):1221-1227

Cancer risk following organ transplantation:: a nationwide cohort study in Sweden

Adami J; Gäbel H; Lindelöf B; Ekström K; Rydh B; Glimelius B; Ekbom A; Adami HO; Granath F
Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(4):963-970

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
Article: GASTROENTEROLOGY. 2002;123(5):1428-1435

Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis

Askling J; Linet M; Gridley G; Halstensen TS; Ekström K; Ekbom A
Article: CANCER CAUSES & CONTROL. 2002;13(1):47-53

Childbearing and the risk of leukemia in Sweden

Ekström K; Wuu J; Hsieh CC; Glimelius B; Lambe M
Article: ONCOLOGY REPORTS. 1998;5(4):931-934

Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.

Ekstrom K; Hoffman K; Linne T; Eriksson B; Glimelius B
Article: ANNALS OF ONCOLOGY. 1997;8(2):163-168

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

Glimelius B; Ekström K; Hoffman K; Graf W; Sjödén PO; Haglund U; Svensson C; Enander LK; Linné T; Sellström H; Heuman R
Article: DISEASES OF THE COLON & RECTUM. 1996;39(7):744-749

A pilot study of factors influencing bowel function after colorectal anastomosis.

Graf W; Ekström K; Glimelius B; Påhlman L
Visa fler

Alla övriga publikationer

Corrigendum: LEUKEMIA. 2023;37(10):2142

Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.

Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami H-O; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diepstra A; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JF; Gabbas A; Ghesquières H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van Den Berg A; Van Den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):413-436

Novel precision medicine approaches and treatment strategies in hematological malignancies

Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Ostling P; Cavelier L; Fioretos T; Smedby KE
Letter: ACTA ONCOLOGICA. 2023;62(6):560-564

The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results

Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
Corrigendum: LEUKEMIA. 2023;37(2):504

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Dec, 10.1038/s41375-022-01802-y, 2022)

Mansouri L; Thorvaldsdottir B; Sutton L-A; Karakatsoulis G; Meggendorfer M; Parker H; Nadeu F; Brieghel C; Laidou S; Moia R; Rossi D; Catherwood M; Kotaskova J; Delgado J; Rodriguez-Vicente AE; Benito R; Rigolin GM; Bonfiglio S; Scarfo L; Mattsson M; Davis Z; Gogia A; Rani L; Baliakas P; Foroughi-Asl H; Jylha C; Skaftason A; Rapado I; Miras F; Martinez-Lopez J; de la Serna J; Rivas JMH; Thornton P; Larrayoz MJ; Calasanz MJ; Fesus V; Matrai Z; Bodor C; Smedby KE; Espinet B; Puiggros A; Gupta R; Bullinger L; Bosch F; Tazon-Vega B; Baran-Marszak F; Oscier D; Nguyen-Khac F; Zenz T; Terol MJ; Cuneo A; Hernandez-Sanchez M; Pospisilova S; Mills K; Gaidano G; Niemann CU; Campo E; Strefford JC; Ghia P; Stamatopoulos K; Rosenquist R
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S777

Risk and mortality of testicular cancer in patients with psychiatric or neurodevelopmental disorders

Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KE; Pettersson A; Glimelius I
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):243-261

Application of precision medicine in clinical routine in haematology-Challenges and opportunities

Wasterlid T; Cavelier L; Haferlach C; Konopleva M; Froehling S; Ostling P; Bullinger L; Fioretos T; Smedby KE
Letter: ACTA ONCOLOGICA. 2022;61(7):809-813

Cancer in young adulthood - classifying the intensity of treatment

Hedman C; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Stahl O; Wettergren L; Lampic C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:169-170

RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY

Cordtz R; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love T; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Letter: ACTA ONCOLOGICA. 2022;61(5):597-601

Overall survival and registration of cutaneous T-cell lymphoma patients in Sweden: a multi-center cohort and validation study

Nenonen J; Winther AH; Leijonhufvud E; Belfrage E; Smedby KE; Brauner H
Review: LANCET HAEMATOLOGY. 2022;9(5):e374-e384

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

Thanarajasingam G; Minasian LM; Bhatnagar V; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gormley N; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Kwong YL; Little RF; Matasar MJ; Mateos M-V; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Nair A; Nastoupil L; Robertson K; Sidana S; Smedby KE; Sonneveld P; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Seymour JF; Habermann TM
Letter: HAEMATOLOGICA. 2022;107(3):740-743

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017

Albertsson-Lindblad A; Palsdottir T; Smedby KE; Weibull CE; Glimelius I; Jerkeman M
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(2):437-440

Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

Fjorden K; Ekberg S; Kuric N; Smedby KE; Lagerlof I; Larsen TS; Jorgensen JM; de Nully Brown P; Jerkeman M
Corrigendum: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(6):1407

Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting (vol 35, pg 105, 2021)

Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:81

RISK OF BREAST CANCER BEFORE AND AFTER RHEUMATOID ARTHRITIS, AND THE IMPACT OF HORMONAL FACTORS

Wadstrom H; Pettersson A; Smedby KE; Askling J
Corrigendum: CANCER CAUSES & CONTROL. 2020;31(6):607

Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study (vol 31, pg 451, 2020)

Wade NB; Chang CM; Conti D; Millstein J; Skibola C; Nieters A; Wang SS; De Sanjose S; Kane E; Spinelli JJ; Bracci P; Zhang Y; Slager S; Wang J; Hjalgrim H; Smedby KE; Brown EE; Jarrett RF; Cozen W
Editorial comment: ACTA ONCOLOGICA. 2020;59(3):247-248

Immune checkpoint inhibitors in cancer treatment and potential effect modification by age

Eriksson H; Smedby KE
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):307-308

Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Mofors J; Bjoerk A; Smedby KE; Kvarnstrom M; Forsblad-d'Elia H; Magnusson-Bucher S; Eriksson P; Mandl T; Baecklund E; Nordmark G; Wahren-Herlenius M
Review: LEUKEMIA & LYMPHOMA. 2019;60(13):3116-3131

Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review

Palmarsdottir R; Ovlisen AK; Severinsen MT; Glimelius I; Smedby KE; El-Galaly T
Letter: INTERNATIONAL JOURNAL OF CANCER. 2019;145(6):1706-1707

Author's reply to: A note on competing risks in analyses of cancer-specific mortality

Benoni H; Smedby KE; Eloranta S
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2019;186(3):e24-e27

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.

Ellin F; Maurer MJ; Srour L; Farooq U; Jerkeman M; Connors JM; Smedby KE; Bennani NN; Ansell SM; Slack GW; Cerhan JR; Relander T; Feldman AL; Savage KJ
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):759-760

Is Longer Progression-Free Survival a Goal Worth Pursuing in Follicular Lymphoma? Reply

Lockmer S; Ostenstad B; Hagberg H; Holte H; Wahlin BE; Wader KF; Smedby KE; Brown P; Kimby E
Conference publication: BLOOD. 2018;132:4200

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Smedby KE; Harrysson S; Andersson P-O; Enblad G; Ekberg S; Jerkeman M; Eloranta S
Editorial comment: LANCET HAEMATOLOGY. 2018;5(11):e510-e511

Real-world evidence in safety assessment of new treatments

Smedby KE; Eloranta S
Letter: ANNALS OF ONCOLOGY. 2018;29(8):1882-1883

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

Wasterlid T; Biccler JL; Brown PN; Bogsted M; Enblad G; Jorgensen JM; Christensen JH; Wahlin BE; Smedby KE; El-Galaly TC; Jerkeman M
Letter: HAEMATOLOGICA. 2018;103(4):E158-E161

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Baliakas P; Mattsson M; Hadzidimitriou A; Minga E; Agathangelidis A; Sutton L-A; Scarfo L; Davis Z; Yan X-J; Plevova K; Sandberg Y; Vojdeman FJ; Tzenou T; Chu CC; Veronese S; Mansouri L; Smedby KE; Giudicelli V; Nguyen-Khac F; Panagiotidis P; Juliusson G; Anagnostopoulos A; Lefranc M-P; Trentin L; Catherwood M; Montillo M; Niemann CU; Langerak AW; Pospisilova S; Stavroyianni N; Chiorazzi N; Oscier D; Jelinek DF; Shanafelt T; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 2017;282(5):360-370

The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections.

Smedby KE; Ponzoni M
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2017;282(5):358-359

Introduction to the symposium 'Targeted therapy in B-cell malignancies'

Smedby KE; Rosenquist R
Letter: HAEMATOLOGICA. 2016;101(9):e369-e373

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Navrkalova V; Young E; Baliakas P; Radova L; Sutton L-A; Plevova K; Mansouri L; Ljungstrom V; Ntoufa S; Davis Z; Juliusson G; Smedby KE; Belessi C; Panagiotidis P; Touloumenidou T; Davi F; Langerak AW; Ghia P; Strefford JC; Oscier D; Mayer J; Stamatopoulos K; Pospisilova S; Rosenquist R; Trbusek M
Letter: HAEMATOLOGICA. 2016;101(2):e63-e65

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi S; Baliakas P; Cortese D; Mattsson M; Engvall M; Smedby KE; Juliusson G; Sutton L-A; Mansouri L
Corrigendum: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):610-611

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study (vol 9, pg 599, 2015)

Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Letter: LEUKEMIA. 2015;29(3):748-751

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

Sava GP; Speedy HE; Di Bernardo MC; Dyer MJS; Holroyd A; Sunter NJ; Marr H; Mansouri L; Deaglios S; Karabon L; Frydecka I; Jamroziak K; Woszczyk D; Juliusson G; Smedby KE; Jayne S; Majid A; Wang Y; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Editorial comment: ACTA ONCOLOGICA. 2014;53(6):721-723

Cancer survivorship and work loss--what are the risks and determinants?

Smedby KE
Letter: LEUKEMIA. 2014;28(3):710-713

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort

Cortese D; Sutton L-A; Cahill N; Smedby KE; Geisler C; Gunnarsson R; Juliusson G; Mansouri L; Rosenquist R
Letter: LEUKEMIA. 2014;28(3):694-696

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia

Mansouri L; Sutton L-A; Ljungstrom V; Sorqvist EF; Gunnarsson R; Smedby KE; Juliusson G; Stamatopoulos K; Nilsson M; Rosenquist R
Review: SEMINARS IN CANCER BIOLOGY. 2014;24:61-70

Lymphoma development in patients with autoimmune and inflammatory disorders - What are the driving forces?

Baecklund E; Smedby KE; Sutton L-A; Askling J; Rosenquist R
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:83

Comparison of lymphomas in primary and secondary Sjogren's syndrome

Vasaitis L; Nordmark G; Askling J; Ekstrom-Smedby K; Backlin C; Sundstrom C; Theander E; Baecklund E
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(6):858-862

X chromosome-wide association study of follicular lymphoma.

Conde L; Foo J-N; Riby J; Liu J; Darabi H; Hjalgrim H; Bracci PM; Smedby KE; Skibola CF
Review: ANNALS OF ONCOLOGY. 2013;24(9):2245-2255

Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)

Kamper-Jorgensen M; Rostgaard K; Glaser SL; Zahm SH; Cozen W; Smedby KE; Sanjose S; Chang ET; Zheng T; La Vecchia C; Serraino D; Monnereau A; Kane EV; Miligi L; Vineis P; Spinelli JJ; McLaughlin JR; Pahwa P; Dosman JA; Vornanen M; Foretova L; Maynadie M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Hjalgrim H
Letter: LEUKEMIA. 2013;27(2):512-514

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia

Mansouri L; Cahill N; Gunnarsson R; Smedby KE; Tjonnfjord E; Hjalgrim H; Juliusson G; Geisler C; Rosenquist R
Conference publication: HAEMATOLOGICA. 2012;97:50

450K DNA METHYLATION ARRAY ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS GLOBAL METHYLATION TO BE RELATIVELY STABLE OVER TIME AND SIMILAR IN CLL CELLS DERIVED FROM DIFFERENT ANATOMICAL COMPARTMENTS

Cahill N; Bergh AC; Goransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Ekstrom-Smedby K; Sundstrom C; Juliusson G; Rosen A; Rosenquist R
Review: SEMINARS IN CANCER BIOLOGY. 2011;21(5):293-298

Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.

Smedby KE; Hjalgrim H
Review: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;172(6):621-630

Birth Order and Risk of Non-Hodgkin Lymphoma-True Association or Bias?

Grulich AE; Vajdic CM; Falster MO; Kane E; Smedby KE; Bracci PM; de Sanjose S; Becker N; Turner J; Martinez-Maza O; Melbye M; Engels EA; Vineis P; Costantini AS; Holly EA; Spinelli JJ; La Vecchia C; Zheng T; Chiu BCH; Franceschi S; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson RK; Cerhan JR; Breen EC; Birmann B; Cozen W
Letter: LEUKEMIA. 2010;24(1):211-215

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

Gunnarsson R; Isaksson A; Mansouri M; Goransson H; Jansson M; Cahill N; Rasmussen M; Staaf J; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Juliusson G; Rosenquist R
Meeting abstract: BLOOD. 2009;114(22):516

LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia

Kaderi MA; Kanduri M; Mansouri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Juliusson G; Jurlander J; Rosenquist R
Conference publication: BLOOD. 2009;114(22):114-115

Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis

Jarrett R; Johnson PCD; Rostgaard K; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami HO; Glimelius B; Dutoit SH; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander F; Melbye M; Hjalgrim H
Review: JOURNAL OF INTERNAL MEDICINE. 2008;264(6):514-527

Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update

Smedby KE; Askling J; Mariette X; Baecklund E
Conference publication: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2007;37:58

Allergy and Hodgkin lymphorna -: an epidemiological investigation

Hjalgrim H; Ekstrom-Smedby K; Rostgaard K
Review: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(11):2069-2077

Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics

Ekstrom Smedby K; Baecklund E; Askling J
Review: ACTA ONCOLOGICA. 2006;45(3):258-271

Epidemiology and etiology of non-Hodgkin lymphoma -: a review

Ekström-Smedby K
Thesis / dissertation: 2005

Ultraviolet light, autoimmune disorders and the etiology of malignant lymphomas

Ekström Smedby, Karin
Visa fler

Forskningsbidrag

Upptag och utfall av nya behandlingar vid lymfom i ett nationellt perspektiv

Cancerfonden

1 January 2024 - 31 December 2026

Anställningar

Professor/Biträdande Överläkare, Medicin, Solna, Karolinska Institutet, 2021-

Examina och utbildning

Docent, Epidemiologi, Karolinska Institutet, 2010
MEDICINE DOKTORSEXAMEN, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2005

Handledare

Erik Boberg, 2023
Linn Deleskog Spångberg, 2022
Johanna Borg Bruchfeld, Sex-related differences in incidence and outcomes among patients with lymphoma: epidemiological and biological perspectives, https://ki.se/en/people/johanna-borg-bruchfeld, 2021
Joshua Entrop, Childbearing after modern-day intensive immunochemotherapy in young Hodgkin and non-Hodgkin lymphoma survivors, https://ki.se/en/people/joshua-entrop, 2020
Joel Joelsson, 2019
Stina Fuentes, Adverse effects and quality of life after radiotherapy and surgery for rectal cancer - a randomized controlled trial enriched with register data, 2016

Om mig

Utvalda publikationer

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI